Carilion Medical Center
1906 Belleview Ave SE, 
Roanoke, VA 

Overview

Mandy M Atkinson is a Hematologist and an Oncologist in Roanoke, Virginia. Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Embryonal Tumor with Multilayered Rosettes, Adult Soft Tissue Sarcoma, and Splenectomy.

Her clinical research consists of co-authoring 2 peer reviewed articles and participating in 27 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Hematology
Oncology

Licenses

Pediatrics in VA

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
HealthKeepers
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Piedmont
  • HMO
  • POS
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 6 Less Insurance Carriers -

Locations

Carilion Medical Center
1906 Belleview Ave SE, Roanoke, VA 24014

Additional Areas of Focus

Dr. M Atkinson has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


27 Clinical Trials

A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
Neuroblastoma Biology Studies
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL
Treatment of Patients With Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-Lineage Lymphoblastic Lymphoma (B-LLy)
Renal Tumors Classification, Biology, and Banking Study
Key Adverse Events After Childhood Cancer
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic Acid
View 26 Less Clinical Trials
Similar Doctors
Expertise in
76
conditions
Expertise in
76
conditions

Blue Ridge Cancer Center

2013 Jefferson St SW, 
Roanoke, VA 
 (0.1 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Matthew Skelton is a Hematologist in Roanoke, Virginia. Dr. Skelton is highly rated in 76 conditions, according to our data. His top areas of expertise are X-Linked Creatine Deficiency, Neuroendocrine Tumor, Lung Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Skelton is currently accepting new patients.

Expertise in
65
conditions
Expertise in
65
conditions

Blue Ridge Cancer Center

2013 Jefferson St SW, 
Roanoke, VA 
 (0.1 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Suzan Merten is an Oncologist in Roanoke, Virginia. Dr. Merten is highly rated in 65 conditions, according to our data. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Familial Colorectal Cancer, Inflammatory Breast Cancer, and Bone Marrow Aspiration. Dr. Merten is currently accepting new patients.

Expertise in
16
conditions
Expertise in
16
conditions

Carilion Clinic Gynecologic Oncology

1 Riverside Cir Ste 300, 
Roanoke, VA 
 (1.7 miles away)
Languages Spoken:
English
Offers Telehealth

Janet L Osborne is an Oncologist in Roanoke, Virginia. Dr. L Osborne is highly rated in 16 conditions, according to our data. Her top areas of expertise are Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, Ovarian Carcinosarcoma, Bladder Reconstruction, and Oophorectomy.

Frequently Asked Questions about Dr. Mandy M Atkinson

How do I make an appointment with Dr. Mandy M Atkinson?

You can book an appointment with Dr. Mandy M Atkinson by calling their office at 540-981-7376. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mandy M Atkinson a top-rated expert for Acute Lymphoblastic Leukemia (ALL)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mandy M Atkinson is classified as an Experienced expert for Acute Lymphoblastic Leukemia (ALL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mandy M Atkinson specialize in?

While Dr. Mandy M Atkinson is a Hematology, they have specific expertise in Acute Lymphoblastic Leukemia (ALL), Leukemia, and Embryonal Tumor with Multilayered Rosettes. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Mandy M Atkinson participate in research or clinical trials?

Yes. Dr. Mandy M Atkinson has published 2 articles and abstracts on conditions like Acute Lymphoblastic Leukemia (ALL). You can view a list of Dr. Mandy M Atkinson's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mandy M Atkinson accept my insurance?

Dr. Mandy M Atkinson accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 540-981-7376 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. M Atkinson's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile